Michael Sherman, MD, MBA, MS | Venture Partner
RA Capital Management

Dr. Michael Sherman serves as venture partner at RA Capital Management, a $10 billion multi-stage investment manager, dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, diagnostics, services, and research tools. Prior to joining RA, he served as executive vice president and chief medical officer at Point32Health, formed by the merger of Harvard Pilgrim Health Care and Tufts Health Plan, two leading not-for-profit health plans insuring over 2 million members. Prior to the merger, Dr. Sherman served as chief medical officer of Harvard Pilgrim Health Care, nationally recognized for both innovation and quality, and he has been widely recognized as a pioneer in bringing advances in transformational therapeutics, precision medicine, and digital therapeutics to the market. Dr. Sherman holds board appointments with several well-respected nonprofit organizations, including the Personalized Medicine Coalition, the Harvard Business School Healthcare Initiative, and NEHI (Network for Excellence in Health Innovation). Dr, Sherman has also served on the advisory board of the Institute for Clinical and Economic Review (ICER), the board of overseers of Boston’s internationally renowned Museum of Science, and the Massachusetts Rare Disease Advisory Council. Prior to joining Harvard Pilgrim in 2011, Dr. Sherman served as corporate medical director for physician strategies at Humana. He also served as vice president of network and consumer solutions for UnitedHealth Group’s subsidiary Ingenix (now part of Optum) and as chief business development officer for United’s Medicare Part D business. Formerly, Dr. Sherman held management roles at Thomson Medstat (now part of IBM Watson Health); Immusol, a San Diego-based biotechnology company; HealthAllies, an organization created to provide discretionary medical benefits to the cash- pay market, which UnitedHealth Group purchased; and Da Vita, a national provider of dialysis services. Before pursuing an M.B.A. at Harvard Business School, Dr. Sherman received his M.D. from Yale and practiced as a cardiac anesthesiologist. He also holds a B.A. in Anthropology and Natural Sciences and an M.S. in Biomedical Anthropology from the University of Pennsylvania.